Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001182481 | SCV000320006 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2015-08-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000587882 | SCV000695604 | likely benign | not specified | 2019-08-28 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000680522 | SCV000807924 | likely benign | Marfan syndrome | 2018-06-01 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001182481 | SCV001347943 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-07-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002059039 | SCV002440412 | likely benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2021-08-26 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000680522 | SCV004823111 | likely benign | Marfan syndrome | 2023-12-01 | criteria provided, single submitter | clinical testing |